Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Limited Cross-Protection against Infectious Bronchitis Provided by Recombinant Infectious Bronchitis Viruses Expressing Heterologous Spike Glycoproteins

22 Jun 2020

Abstract excerpt

infectious bronchitis virus (IBV) causes an economically important respiratory disease of poultry. Protective immunity is associated with the major structural protein, spike (S) glycoprotein, which induces neutralising antibodies and defines the serotype. Cross-protective immunity between serotypes is limited and can be difficult to predict. In this study, the ability of two recombinant IBV vaccine candidates,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32580371
DOI: 10.3390/vaccines8020330

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Limited Cross-Protection against Infectious Bronchitis Provided by Recombinant Infectious Bronchitis Viruses Expressing Heterologous Spike GlycoproteinsPMID 32580371Read ↗

Recombinant Infectious Bronchitis Viruses Expressing Chimeric Spike Glycoproteins Induce Partial Protective Immunity against Homologous Challenge despite Limited ReplicationIn VivoSemantic proximity Read ↗

A Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Belonging to the 4/91 SerotypeSemantic proximity Read ↗

Examining the potential of rationally designed recombinant Infectious Bronchitis Virus as a vaccine against Infectious BronchitisSemantic proximity Read ↗

Recombinant Infectious Bronchitis Coronavirus Beaudette with the Spike Protein Gene of the Pathogenic M41 Strain Remains Attenuated but Induces Protective ImmunitySemantic proximity Read ↗

Relationship between sequence variation in the S1 spike protein of infectious bronchitis virus and the extent of cross‐protection<i>in vivo</i>Semantic proximity Read ↗

Coronavirus avian infectious bronchitis virusSemantic proximity Read ↗

Modification of the avian coronavirus infectious bronchitis virus for vaccine developmentSemantic proximity Read ↗

Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Demonstrates that the Spike Protein Is a Determinant of Cell TropismSemantic proximity Read ↗

Protection against infectious bronchitis virus by spike ectodomain subunit vaccineSemantic proximity Read ↗

The S2 Glycoprotein Subunit Determines Intestinal Tropism in Infectious Bronchitis VirusSemantic proximity Read ↗

Analysis of antigenicity and pathogenicity reveals major differences among QX-like infectious bronchitis viruses and other serotypes.Semantic proximity Read ↗

Effects of hypervariable regions in spike protein on pathogenicity, tropism, and serotypes of infectious bronchitis virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.